Glipizide and Metformin Hydrochloride 5 mg; 500 mg Tablet, Film Coated, 100-count — NDC 65841-661-01 (Billing 65841-0661-01)
This is a package of 100 tablets of Glipizide and Metformin Hydrochloride 5 mg; 500 mg Tablet, Film Coated from Zydus Lifesciences Limited, marketed since May 2016 and currently FDA-listed. It is the main listing for this product, which comes in 4 package sizes.
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
- RxCUI (RxNorm): 861731
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
RxNorm drug class
This medicine belongs to the Sulfonylurea class.
Where does this data come from?
- RxClass (NLM) · catalog refreshed Oct 1, 2026
Clinical
Glipizide is used along with diet and exercise, and sometimes with other medications, to treat type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in the blood). Glipizide is in a class of medications called sulfonylureas. Glipizide lowers blood sugar by causing the pancreas to produce insulin (a natural substance that is needed to break down sugar in the body) and helping the body use insulin efficiently. This medication will only help lower blood sugar in people whose bodies produce insulin naturally. Glipizide is not...
Read the full MedlinePlus article ↗Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · Q2 2026 | $0.3628 | $36.28 / 100 tablets |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 3, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 65841-0661-01 You're viewing this Main listing | 100 TABLET, FILM COATED in 1 BOTTLE | 2016-05-05 | — | Active |
| 65841-0661-10 65841-661-10 | 1000 TABLET, FILM COATED in 1 BOTTLE | 2016-05-05 | — | Active |
| 65841-0661-16 65841-661-16 | 90 TABLET, FILM COATED in 1 BOTTLE | 2016-05-05 | — | Active |
| 65841-0661-77 65841-661-77 | 10 BLISTER PACK in 1 CARTON / 10 TABLET, FILM COATED in 1 BLISTER PACK | 2016-05-05 | — | Active |
Pack size FAQ
What quantity is in this package?
How does this package differ from NDC 65841-0661-16?
What NDC number is used to bill for this package of Glipizide and Metformin Hydrochloride 5 mg; 500 mg Tablet, Film Coated?
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Glipizide and Metformin Hydrochloride 5 mg/1; 500 mg 00093-7457-01 | Teva | 100 tablets | $0.202 | AB | Availability likely | — |
| Glipizide and Metformin HCl 5 mg/1; 500 mg 23155-0117-01 | Heritage | 100 tablets | $0.202 | AB | Availability likely | — |
| Glipizide and metformin hcl 5 mg/1; 500 mg 62135-0733-60 | Chartwell | 60 tablets | $0.202 | AB | Availability likely | — |
| Glipizide and Metformin Hydrochloride 5 mg/1; 500 mg 68382-0186-01 | Zydus | 100 tablets | $0.202 | AB | Availability likely | — |
| Glipizide and Metformin Hydrochloride 5 mg/1; 500 mg 42291-0306-01 | AvKARE | 100 tablets | — | AB | FDA listed | — |
| Glipizide and Metformin Hydrochloride 5 mg/1; 500 mg 50090-2556-00 | A-S | 180 tablets | — | AB | FDA listed | — |
| Glipizide and Metformin Hydrochloride 5 mg/1; 500 mgthis 65841-0661-01 | Zydus | 100 tablets | — | AB | FDA listed | — |
| Glipizide and Metformin Hydrochloride 5 mg/1; 500 mg 70518-0373-00 | REMEDYREPACK | 90 tablets | — | AB | FDA listed | — |
| Glipizide and Metformin HCl 5 mg/1; 500 mg 71205-0270-30 | Proficient | 30 tablets | — | AB | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Oct 3, 2026
- CMS NADAC weekly file
Availability & generic status
This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.
Where does this data come from?
- FDA Orange Book · refreshed Oct 3, 2026
What it looks like
Where does this data come from?
- FDA label on DailyMed · label index refreshed Oct 1, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII OP1R32D61U
Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
-
UNII M28OL1HH48
Croscarmellose sodium is a plant-based substance derived from cellulose. It acts as a disintegrant, helping tablets and capsules break down quickly in the digestive system so the medicine can be absorbed.
-
UNII 1K09F3G675
Ferric oxide red is an inorganic iron compound used as a colorant in medicines. It gives tablets, capsules, or other dosage forms a red or reddish tint for identification and appearance.
-
UNII 3NXW29V3WO
Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
-
UNII 70097M6I30
Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
-
UNII 3WJQ0SDW1A
Polyethylene glycol is a synthetic liquid or solid polymer used in medicines as a solvent, lubricant, and humectant. It helps dissolve active ingredients, reduces friction during manufacturing, and retains moisture in the final product.
-
UNII FZ989GH94E
Povidone is a synthetic polymer made from a plastic-like material. It acts as a binder to hold tablet ingredients together and as a disintegrant to help the tablet break apart in your stomach so the medicine can be absorbed.
-
UNII 15FIX9V2JP
Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.
8 inactive ingredients listed in the exact product block matched to this NDC.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Oct 1, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
Full prescribing information FDA SPL
📄 Package Label / Principal Display Panel ▾
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 65841-659-01 in bottle of 100 tablets Glipizide and Metformin Hydrochloride Tablets USP, 2.5 mg/250 mg R x only 100 tablets NDC 65841-660-01 in bottle of 100 tablets Glipizide and Metformin Hydrochloride Tablets USP, 2.5 mg/500 mg R x only 100 tablets NDC 65841-661-01 in bottle of 100 tablets Glipizide and Metformin Hydrochloride Tablets USP, 5 mg/500 mg R x only 100 tablets Glipizide and Metformin HCL Tablets Glipizide and metformin HCL Tablets Glipizide and metformin HCL Tablets
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | ✓ Available |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |